English | Español

Bristol-Myers Squibb
+ Technology/Innovation
Jamie Barrand | Mar 20, 2016

Bristol-Myers Squibb researchers to present data on Opdivo, Yervoy
+ Technology/Innovation
Jamie Barrand | Mar 11, 2016

Opdivo under consideration in Europe for new indications
+ Technology/Innovation
Jamie Barrand | Feb 23, 2016

Bristol-Myers Squibb's hepatitis C study focuses on Asian populations
+ Technology/Innovation
Jamie Barrand | Feb 18, 2016

Pharmaceutical partnership to focus on high-risk cancer research
+ Technology/Innovation
Jamie Barrand | Feb 10, 2016

FDA expands label for Bristol-Myers Squibb's Daklinza therapy
+ Technology/Innovation
Jamie Barrand | Feb 4, 2016

Pharmaceutical companies investigate anticoagulant agent to reduce strokes
+ Technology/Innovation
Caitlin Nordahl | Jan 29, 2016

FDA expands approved use of Bristol-Myers Squibb’s late-stage melanoma treatment
+ Technology/Innovation
Kasey Schefflin- Emrich | Jan 26, 2016

Bristol-Myers Squibb recognized for advancing multiple myeloma research

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes